{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:42:43Z","timestamp":1791315763321,"version":"4.3.1"},"reference-count":26,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,1]]},"abstract":"<jats:p>The immunosuppressant MMF (mycophenolate mofetil) has increasingly replaced AZA (azathioprine) in renal transplantation. MMF is a prodrug of MPA (mycophenolic acid), which inhibits lymphocyte IMPDH (inosine monophosphate dehydrogenase), thereby drastically decreasing GTP concentrations essential to lymphocyte proliferation in vitro and in vivo. Erythrocyte GTP concentrations are commonly elevated in severe renal disease, but normalize following successful engraftment. Consequently, elevated GTP in renal transplant recipients might signal impending loss of immunosuppression and graft failure. In the present study, we compared erythrocyte nucleotides and plasma metabolites in two groups of 25 patients after renal transplantation, both receiving prednisolone and cyclosporin A, but one group receiving MMF and the other AZA. No patients had recent allograft biopsy evidence of rejection. Erythrocyte GTP concentrations at MMF commencement were 50.4\u00b123.4\u00a0\u03bcmol\/l. An increase occurred during the first 3 months after transplant when MMF was used de novo, stabilizing at 146.7\u00b162.9\u00a0\u03bcmol\/l after 4 months. This was significantly higher (P=2.5\u00d710\u22126) than erythrocyte GTP (40.4\u00b115.9\u00a0\u03bcmol\/l) in the AZA group, which was essentially unchanged from values immediately after successful transplantation. The effect of MMF on erythrocyte GTP levels was reversible, since GTP levels fell when MMF therapy was terminated. The results demonstrate paradoxically high GTP concentrations in erythrocytes of renal transplant patients receiving MMF. MPA may stabilize reticulocyte IMPDH, allowing the protein to persist during erythropoiesis. This behaviour is in marked contrast with the decrease in GTP levels seen in white blood cells of patients on chronic MMF therapy.<\/jats:p>","DOI":"10.1042\/cs20030331","type":"journal-article","created":{"date-parts":[[2004,6,23]],"date-time":"2004-06-23T13:20:21Z","timestamp":1087996821000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients"],"prefix":"10.1042","volume":"107","author":[{"given":"David","family":"GOLDSMITH","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, Guy's Hospital, London SE1 9RT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"CARREY","sequence":"additional","affiliation":[{"name":"Purine Research Unit, Guy's Hospital, London SE1 9RT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"EDBURY","sequence":"additional","affiliation":[{"name":"Purine Research Unit, Guy's Hospital, London SE1 9RT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard T.","family":"SMOLENSKI","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, Debinki 7 Str., 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr.","family":"JAGODZINSKI","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Debinki 7 Str., 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Anne","family":"SIMMONDS","sequence":"additional","affiliation":[{"name":"Purine Research Unit, Guy's Hospital, London SE1 9RT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2004,6,23]]},"reference":[{"key":"2021120120221092000_B1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolic acid and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"suppl 2","key":"2021120120221092000_B2","first-page":"10","article-title":"In vitro immunosuppressive effects of mycophenolic acid and an ester prodrug, RS-61443","volume":"23","author":"Allison","year":"1991","journal-title":"Transplant Proc."},{"key":"2021120120221092000_B3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0041-1345(00)02302-2","article-title":"Place of mycophenolate mofetil in renal transplantation","volume":"33","author":"Grinyo","year":"2001","journal-title":"Transplant Proc."},{"key":"2021120120221092000_B4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00007890-200003150-00038","article-title":"Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T-lymphocytes","volume":"69","author":"Qiu","year":"2000","journal-title":"Transplantation"},{"key":"2021120120221092000_B5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(00)00297-7","article-title":"In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes","volume":"300","author":"Heinschink","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"2021120120221092000_B6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S1053-2498(02)00440-0","article-title":"Effect of mycophenolate mofetil on lymphocyte activation in heart transplant recipients","volume":"231","author":"Weigel","year":"2002","journal-title":"J. Heart Lung Transplant"},{"key":"2021120120221092000_B7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.1985.tb02847.x","article-title":"Rapid correction of red cell nucleotide abnormalities following successful renal transplantation","volume":"61","author":"Rejman","year":"1985","journal-title":"Br. J. Haematol."},{"key":"2021120120221092000_B8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-8981(03)00294-8","article-title":"Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure","volume":"335","author":"Carrey","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"2021120120221092000_B9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0009-8981(95)06088-U","article-title":"Demonstration of induction of erythrocyte IMP-dehydrogenase activity in ribavirin-treated patients using an HPLC-linked method","volume":"238","author":"Montero","year":"1995","journal-title":"Clin. Chim. Acta"},{"key":"2021120120221092000_B10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/0-306-46843-3_28","article-title":"Guanosine-5\u2032-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil","volume":"486","author":"Griesmacher","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021120120221092000_B11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1067\/mcp.2001.114166","article-title":"Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients","volume":"69","author":"Wiegel","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"2021120120221092000_B12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0009-9236(99)90085-1","article-title":"Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil","volume":"65","author":"Sanquer","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"2021120120221092000_B13","first-page":"201","article-title":"Inosine monophosphate dehydrogenase: consideration of structure, kinetics and therapeutic potential","volume":"35","author":"Saunders","year":"2000","journal-title":"Ann. Rep. Med. Chem."},{"key":"2021120120221092000_B14","first-page":"258","article-title":"Proliferation-linked regulation of type II IMP dehydrogenase in human normal lymphocytes and HL-60 leukaemic cells","volume":"52","author":"Nagai","year":"1992","journal-title":"Cancer Res."},{"key":"2021120120221092000_B15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0065-2571(92)90008-N","article-title":"Regulation of GTP biosynthesis","volume":"32","author":"Weber","year":"1992","journal-title":"Adv. Enzyme Regul."},{"key":"2021120120221092000_B16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0021-9258(18)33286-1","article-title":"Characterisation of mutant murine lymphoma cells with altered inosinate dehydrogenase","volume":"258","author":"Ullman","year":"1983","journal-title":"J. Biol. Chem."},{"key":"2021120120221092000_B16a","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/CS20030332","article-title":"Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes","volume":"107","author":"Jagodzinski","year":"2004","journal-title":"Clin. Sci."},{"key":"2021120120221092000_B17","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1074\/jbc.273.34.21682","article-title":"Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans","volume":"273","author":"R\u00fcckemann","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021120120221092000_B18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00007890-200208270-00013","article-title":"Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients","volume":"74","author":"Sadek","year":"2002","journal-title":"Transplantation"},{"key":"2021120120221092000_B19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00007691-199512000-00024","article-title":"Mycophenolic acid: measurement and relationship to pharmacologic effects","volume":"17","author":"Shaw","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"2021120120221092000_B20","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/clinchem\/43.12.2312","article-title":"IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide","volume":"43","author":"Griesmacher","year":"1997","journal-title":"Clin. Chem."},{"key":"2021120120221092000_B21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0702399","article-title":"Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil","volume":"126","author":"Shipkova","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"2021120120221092000_B22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007691-200002000-00002","article-title":"Identification of UDP glucuronyltransferases involved in the metabolism and clearance of mycophenolic acid","volume":"22","author":"Mackenzie","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"2021120120221092000_B23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bcp.2003.09.043","article-title":"Regulation of IMPDH Type I and Type II isoforms in human lymphocytes","volume":"67","author":"Jain","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"2021120120221092000_B24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell (Cambridge, Mass.)"},{"key":"2021120120221092000_B25","doi-asserted-by":"crossref","first-page":"19421","DOI":"10.1074\/jbc.271.32.19421","article-title":"Conformational changes and stabilization of inosine 5\u2032-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid","volume":"271","author":"Nimmesgern","year":"1996","journal-title":"J. Biol. Chem."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/107\/1\/63\/435588\/cs1070063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/107\/1\/63\/435588\/cs1070063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T20:26:14Z","timestamp":1638390374000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/107\/1\/63\/67513\/Mycophenolate-mofetil-an-inhibitor-of-inosine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,23]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20030331","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,23]]}}}